nodes	percent_of_prediction	percent_of_DWPC	metapath
Pralatrexate—SLC19A1—Metabolism of folate and pterines—MTHFR—cervical cancer	0.0753	0.158	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism of folate and pterines—MTHFR—cervical cancer	0.064	0.134	CbGpPWpGaD
Pralatrexate—SLC19A1—female reproductive system—cervical cancer	0.0349	0.0713	CbGeAlD
Pralatrexate—FPGS—Fluoropyrimidine Activity—SMUG1—cervical cancer	0.0324	0.068	CbGpPWpGaD
Pralatrexate—FPGS—decidua—cervical cancer	0.0295	0.0604	CbGeAlD
Pralatrexate—FPGS—endometrium—cervical cancer	0.028	0.0573	CbGeAlD
Pralatrexate—FPGS—mammalian vulva—cervical cancer	0.0271	0.0554	CbGeAlD
Pralatrexate—DHFR—Metabolism of folate and pterines—MTHFR—cervical cancer	0.0268	0.0562	CbGpPWpGaD
Pralatrexate—FPGS—female reproductive system—cervical cancer	0.0232	0.0475	CbGeAlD
Pralatrexate—FPGS—Fluoropyrimidine Activity—MTHFR—cervical cancer	0.0227	0.0476	CbGpPWpGaD
Pralatrexate—FPGS—female gonad—cervical cancer	0.0211	0.0432	CbGeAlD
Pralatrexate—FPGS—vagina—cervical cancer	0.021	0.0429	CbGeAlD
Pralatrexate—SLC19A1—lymph node—cervical cancer	0.0204	0.0417	CbGeAlD
Pralatrexate—TYMS—uterine cervix—cervical cancer	0.0203	0.0416	CbGeAlD
Pralatrexate—DHFR—uterine cervix—cervical cancer	0.0201	0.0412	CbGeAlD
Pralatrexate—DHFR—decidua—cervical cancer	0.0192	0.0392	CbGeAlD
Pralatrexate—DHFR—renal system—cervical cancer	0.0188	0.0385	CbGeAlD
Pralatrexate—TYMS—endometrium—cervical cancer	0.0184	0.0376	CbGeAlD
Pralatrexate—DHFR—endometrium—cervical cancer	0.0182	0.0372	CbGeAlD
Pralatrexate—TYMS—mammalian vulva—cervical cancer	0.0178	0.0364	CbGeAlD
Pralatrexate—DHFR—mammalian vulva—cervical cancer	0.0176	0.036	CbGeAlD
Pralatrexate—DHFR—uterus—cervical cancer	0.0168	0.0343	CbGeAlD
Pralatrexate—DHFR—E2F transcription factor network—YY1—cervical cancer	0.0168	0.0352	CbGpPWpGaD
Pralatrexate—SLC19A1—Folate Metabolism—MTHFR—cervical cancer	0.0153	0.0321	CbGpPWpGaD
Pralatrexate—TYMS—female reproductive system—cervical cancer	0.0152	0.0311	CbGeAlD
Pralatrexate—DHFR—female reproductive system—cervical cancer	0.0151	0.0308	CbGeAlD
Pralatrexate—TYMS—E2F transcription factor network—YY1—cervical cancer	0.0146	0.0307	CbGpPWpGaD
Pralatrexate—TYMS—female gonad—cervical cancer	0.0139	0.0283	CbGeAlD
Pralatrexate—TYMS—vagina—cervical cancer	0.0138	0.0282	CbGeAlD
Pralatrexate—DHFR—female gonad—cervical cancer	0.0137	0.0281	CbGeAlD
Pralatrexate—DHFR—vagina—cervical cancer	0.0136	0.0279	CbGeAlD
Pralatrexate—FPGS—lymph node—cervical cancer	0.0136	0.0278	CbGeAlD
Pralatrexate—DHFR—Fluoropyrimidine Activity—SMUG1—cervical cancer	0.0135	0.0284	CbGpPWpGaD
Pralatrexate—Folic Acid—MTHFR—cervical cancer	0.0128	0.373	CrCbGaD
Pralatrexate—Tetrahydrofolic acid—MTHFR—cervical cancer	0.0128	0.373	CrCbGaD
Pralatrexate—SLC19A1—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—cervical cancer	0.0123	0.0258	CbGpPWpGaD
Pralatrexate—TYMS—Fluoropyrimidine Activity—SMUG1—cervical cancer	0.0118	0.0248	CbGpPWpGaD
Pralatrexate—DHFR—One Carbon Metabolism—MTHFR—cervical cancer	0.0108	0.0227	CbGpPWpGaD
Pralatrexate—FPGS—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—cervical cancer	0.0104	0.0219	CbGpPWpGaD
Pralatrexate—DHFR—Trans-sulfuration and one carbon metabolism—MTHFR—cervical cancer	0.0097	0.0204	CbGpPWpGaD
Pralatrexate—DHFR—Fluoropyrimidine Activity—MTHFR—cervical cancer	0.00946	0.0199	CbGpPWpGaD
Pralatrexate—TYMS—One Carbon Metabolism—MTHFR—cervical cancer	0.00942	0.0198	CbGpPWpGaD
Pralatrexate—TYMS—lymph node—cervical cancer	0.00892	0.0182	CbGeAlD
Pralatrexate—DHFR—lymph node—cervical cancer	0.00883	0.018	CbGeAlD
Pralatrexate—Methotrexate—MTHFR—cervical cancer	0.00876	0.255	CrCbGaD
Pralatrexate—FPGS—Fluoropyrimidine Activity—TP53—cervical cancer	0.0086	0.0181	CbGpPWpGaD
Pralatrexate—TYMS—Trans-sulfuration and one carbon metabolism—MTHFR—cervical cancer	0.00846	0.0178	CbGpPWpGaD
Pralatrexate—TYMS—Fluoropyrimidine Activity—MTHFR—cervical cancer	0.00826	0.0173	CbGpPWpGaD
Pralatrexate—SLC19A1—Folate Metabolism—TP53—cervical cancer	0.00581	0.0122	CbGpPWpGaD
Pralatrexate—DHFR—Folate Metabolism—MTHFR—cervical cancer	0.00543	0.0114	CbGpPWpGaD
Pralatrexate—TYMS—Circadian rythm related genes—UBE3A—cervical cancer	0.005	0.0105	CbGpPWpGaD
Pralatrexate—DHFR—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—cervical cancer	0.00436	0.00915	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—RARB—cervical cancer	0.00425	0.00892	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—WNT2—cervical cancer	0.00379	0.00796	CbGpPWpGaD
Pralatrexate—DHFR—Fluoropyrimidine Activity—TP53—cervical cancer	0.00359	0.00754	CbGpPWpGaD
Pralatrexate—FPGS—Disease—WNT2—cervical cancer	0.00322	0.00676	CbGpPWpGaD
Pralatrexate—TYMS—Fluoropyrimidine Activity—TP53—cervical cancer	0.00313	0.00658	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—CA9—cervical cancer	0.003	0.00629	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—WNT5A—cervical cancer	0.00287	0.00603	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—CA9—cervical cancer	0.00255	0.00535	CbGpPWpGaD
Pralatrexate—FPGS—Disease—WNT5A—cervical cancer	0.00244	0.00513	CbGpPWpGaD
Pralatrexate—DHFR—Folate Metabolism—TP53—cervical cancer	0.00206	0.00433	CbGpPWpGaD
Pralatrexate—DHFR—Retinoblastoma (RB) in Cancer—TP53—cervical cancer	0.00165	0.00347	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—HES1—cervical cancer	0.00165	0.00347	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	0.00159	0.00333	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—MTHFR—cervical cancer	0.00145	0.00305	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—TERT—cervical cancer	0.00145	0.00304	CbGpPWpGaD
Pralatrexate—TYMS—Retinoblastoma (RB) in Cancer—TP53—cervical cancer	0.00144	0.00303	CbGpPWpGaD
Pralatrexate—FPGS—Disease—HES1—cervical cancer	0.00141	0.00295	CbGpPWpGaD
Pralatrexate—DHFR—Disease—WNT2—cervical cancer	0.00135	0.00283	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—FGFR3—cervical cancer	0.00133	0.00279	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—NOTCH1—cervical cancer	0.00125	0.00262	CbGpPWpGaD
Pralatrexate—FPGS—Disease—MTHFR—cervical cancer	0.00123	0.00259	CbGpPWpGaD
Pralatrexate—FPGS—Disease—TERT—cervical cancer	0.00123	0.00259	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—MTHFR—cervical cancer	0.00122	0.00255	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	0.0012	0.00252	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	0.00116	0.00243	CbGpPWpGaD
Pralatrexate—FPGS—Disease—FGFR3—cervical cancer	0.00113	0.00237	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—CA9—cervical cancer	0.00106	0.00223	CbGpPWpGaD
Pralatrexate—FPGS—Disease—NOTCH1—cervical cancer	0.00106	0.00223	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—MTHFR—cervical cancer	0.00103	0.00217	CbGpPWpGaD
Pralatrexate—DHFR—Disease—WNT5A—cervical cancer	0.00102	0.00214	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—TERT—cervical cancer	0.001	0.0021	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—MTOR—cervical cancer	0.000935	0.00196	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—CD4—cervical cancer	0.000933	0.00196	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—CA9—cervical cancer	0.000929	0.00195	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	0.000916	0.00192	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—TERT—cervical cancer	0.000875	0.00184	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—CTNNB1—cervical cancer	0.000829	0.00174	CbGpPWpGaD
Pralatrexate—FPGS—Disease—MTOR—cervical cancer	0.000795	0.00167	CbGpPWpGaD
Pralatrexate—FPGS—Disease—CD4—cervical cancer	0.000793	0.00167	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	0.000769	0.00162	CbGpPWpGaD
Pralatrexate—TYMS—Circadian rythm related genes—TP53—cervical cancer	0.000739	0.00155	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—STAT3—cervical cancer	0.000722	0.00152	CbGpPWpGaD
Pralatrexate—FPGS—Disease—CTNNB1—cervical cancer	0.000705	0.00148	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—EGFR—cervical cancer	0.000657	0.00138	CbGpPWpGaD
Pralatrexate—FPGS—Disease—STAT3—cervical cancer	0.000614	0.00129	CbGpPWpGaD
Pralatrexate—DHFR—Disease—HES1—cervical cancer	0.000587	0.00123	CbGpPWpGaD
Pralatrexate—FPGS—Disease—EGFR—cervical cancer	0.000558	0.00117	CbGpPWpGaD
Pralatrexate—DHFR—Disease—MTHFR—cervical cancer	0.000516	0.00108	CbGpPWpGaD
Pralatrexate—DHFR—Disease—TERT—cervical cancer	0.000514	0.00108	CbGpPWpGaD
Pralatrexate—DHFR—Disease—FGFR3—cervical cancer	0.000472	0.000991	CbGpPWpGaD
Pralatrexate—DHFR—Disease—NOTCH1—cervical cancer	0.000443	0.00093	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—MTHFR—cervical cancer	0.000432	0.000907	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—TP53—cervical cancer	0.000382	0.000801	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—MTHFR—cervical cancer	0.000377	0.000791	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—TP53—cervical cancer	0.000333	0.000699	CbGpPWpGaD
Pralatrexate—DHFR—Disease—MTOR—cervical cancer	0.000332	0.000697	CbGpPWpGaD
Pralatrexate—DHFR—Disease—CD4—cervical cancer	0.000331	0.000696	CbGpPWpGaD
Pralatrexate—DHFR—Disease—CTNNB1—cervical cancer	0.000294	0.000618	CbGpPWpGaD
Pralatrexate—DHFR—Disease—STAT3—cervical cancer	0.000257	0.000539	CbGpPWpGaD
Pralatrexate—DHFR—Disease—EGFR—cervical cancer	0.000233	0.00049	CbGpPWpGaD
